Simplex Trading
DNA icon

Simplex Trading’s Ginkgo Bioworks DNA Stock Holding History

Simplex Trading’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$178K Buy
17,995
+10,521
+141% +$88K ﹤0.01% 4859
2026
Q1 		$45.8K Buy
+7,474
New +$62.2K ﹤0.01% 5969
2025
Q4 		– Sell
-23,533
Closed -$343K – 8878
2025
Q3 		$343K Buy
+23,533
New +$282K ﹤0.01% 4294
2025
Q2 		– Sell
-37,775
Closed -$293K – 8868
2025
Q1 		$215K Sell
37,775
-9,328
-20% -$95K ﹤0.01% 4247
2024
Q4 		$462K Buy
+47,103
New +$404K ﹤0.01% 3623
2024
Q3 		– Sell
-5,841
Closed -$58.5K – 8701
2024
Q2 		$78K Sell
5,841
-3,710
-39% -$111K ﹤0.01% 5627
2024
Q1 		$443K Buy
9,551
+2,628
+38% +$136K ﹤0.01% 3967
2023
Q4 		$468K Buy
6,923
+3,726
+117% +$228K ﹤0.01% 3773
2023
Q3 		$231K Sell
3,197
-3,338
-51% -$267K ﹤0.01% 4194
2023
Q2 		$486K Buy
6,535
+6,442
+6,927% +$381K ﹤0.01% 3349
2023
Q1 		$4K Buy
93
+84
+933% +$5.32K ﹤0.01% 8157
2022
Q4 		$0 Buy
9
+3
+50% +$276 ﹤0.01% 9416
2022
Q3 		$0 Sell
6
-1,230
-100% -$147K ﹤0.01% 10087
2022
Q2 		$117K Sell
1,236
-4,909
-80% -$599K ﹤0.01% 5356
2022
Q1 		$990K Buy
+6,145
New +$1.2M ﹤0.01% 2938

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Simplex Trading's DNA Position: Q2 2026 in Review

Simplex Trading increased its Ginkgo Bioworks (DNA) stake by 141% in Q2 2026, buying an estimated $88K and bringing the position to 17,995 shares worth $178K. The position accounts for ﹤0.01% of the portfolio, ranked #4859.

Simplex Trading first reported a position in DNA in Q1 2022 and has held it in 15 quarters since. The position peaked at $990K in Q1 2022. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Simplex Trading held 17,995 shares of Ginkgo Bioworks worth $178K as of Q2 2026.
  • Simplex Trading bought 10,521 Ginkgo Bioworks shares in Q2 2026, an estimated $88K.
  • Ginkgo Bioworks made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #4859 holding.
  • Simplex Trading first reported a position in Ginkgo Bioworks in Q1 2022 and has held it in 15 quarters since.
  • Simplex Trading's Ginkgo Bioworks position peaked at $990K in Q1 2022.
  • 184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.